Latest News and Press Releases

Nes-Ziona, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "U.S. Osteoarthritis Injectables Market Size, Share & Trends Analysis Report by Injection Type (Hyaluronic Acid Injections, Corticosteroids...

Presentation of OA-07 Phase 3 Long-Term Results for Lorecivivint and Preliminary Analysis of OA-21 Trial 12-Week Pain Results

Biosplice Therapeutics Inc. presents results of OA-07 Long-Term Extension Trial for its knee OA drug candidate, lorecivivint.

New York, USA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Knee Osteoarthritis Market to Witness Upsurge in Growth, Assesses DelveInsight | Key Companies To Look Out - Techfields, Centrexion, Biosplice,...

Rockville, Nov. 30, 2022 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global CBD patches market is set to reach US$ 124.6 million in 2023...

New York, USA, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Rich Insights into the Knee Osteoarthritis Clinical Trial Analysis Featuring 60+ Companies and Therapies | DelveInsight The prevalence of Knee...

New York, USA, Oct. 26, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global viscosupplementation market is predicted to generate a revenue of $5,866.2 million and...

Seattle, Oct. 12, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global viscosupplementation market is estimated to be valued at US$ 3,146.7 million in 2022 and is expected to...

NEWARK, Del., April 27, 2022 (GLOBE NEWSWIRE) -- Worldwide viscosupplementation equipment sales are set to be valued at US$ 1.98 Bn in 2022. Detailed industry analysis reveals that the global...